Evaluation of S / F 94 as a proxy for COVID-19 severity (2022)

First Author: Swets M

Attributed to: ISARIC - Coronavirus Clinical Characterisation Consortium (ISARIC-4C) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.09.25.22280081

Publication URI: http://dx.doi.org/10.1101/2022.09.25.22280081

Type: Preprint